We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.27B
AUM Growth
+$54.2M
(+4.5%)
Cap. Flow
+$6.03M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
30.4%
Holding
230
New
24
Increased
67
Reduced
66
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$10.5M |
| 2 |
DuPont de Nemours
DD
|
+$8.45M |
| 3 |
IQVIA
IQV
|
+$7.23M |
| 4 |
Howmet Aerospace
HWM
|
+$6.55M |
| 5 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$6.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$16.4M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$13.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$8.56M |
| 4 |
Tyson Foods
TSN
|
+$7.59M |
| 5 |
Qualcomm
QCOM
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.68% |
| 2 | Financials | 19.47% |
| 3 | Healthcare | 12.46% |
| 4 | Communication Services | 9.96% |
| 5 | Industrials | 9.24% |
Similar funds
CBA
BC
KCM
KC
EWS
SCM
NI
QC
Philadelphia Trust Company's Q4 2017 Portfolio in Review
As of Q4 2017, Philadelphia Trust Company held 230 positions worth $1.27B, up 4.5% from $1.22B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Philadelphia Trust Company's Q4 2017 filing shows 24 new, 67 increased, 66 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 175,285 shares worth $6M. The largest sale was CVS Health, an estimated $16.4M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Philadelphia Trust Company's largest Q4 2017 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 175,285 shares worth $6M.
- Philadelphia Trust Company added most to Emerson Electric in Q4 2017, an estimated $10.5M increase.
- Philadelphia Trust Company's biggest Q4 2017 reduction was CVS Health, cutting an estimated $16.4M.
- Philadelphia Trust Company fully exited Regeneron Pharmaceuticals in Q4 2017, selling an estimated $8.56M.
- Philadelphia Trust Company's ten largest holdings make up 30% of its $1.27B portfolio in Q4 2017.
- Philadelphia Trust Company opened 24 new positions and closed 9 in Q4 2017.
- Philadelphia Trust Company's portfolio value rose 4.5% quarter-over-quarter to $1.27B.
Based on Philadelphia Trust Company's 13F filing for Q4 2017, filed 14 Feb 2018.